Yeoh EE - Search Results

1

Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate.

Yeoh EE, Holloway RH, Fraser RJ, Botten RJ, Di Matteo AC, Moore JW, Schoeman MN, Bartholomeusz FD. Yeoh EE, et al. Am J Gastroenterol. 2004 Feb;99(2):361-9. doi: 10.1111/j.1572-0241.2004.04037.x. Am J Gastroenterol. 2004. PMID: 15046230 Clinical Trial.

2

Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.

Yeoh EE, Holloway RH, Fraser RJ, Botten RJ, Di Matteo AC, Butters J, Weerasinghe S, Abeysinghe P. Yeoh EE, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1072-83. doi: 10.1016/j.ijrobp.2006.06.005. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965866 Clinical Trial.

3

Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial.

Yeoh EE, Botten RJ, Butters J, Di Matteo AC, Holloway RH, Fowler J. Yeoh EE, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1271-8. doi: 10.1016/j.ijrobp.2010.07.1984. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20934277 Clinical Trial.

4

Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.

Yeoh EE, Fraser RJ, McGowan RE, Botten RJ, Di Matteo AC, Roos DE, Penniment MG, Borg MF. Yeoh EE, et al. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):943-55. doi: 10.1016/s0360-3016(02)04146-9. Int J Radiat Oncol Biol Phys. 2003. PMID: 12605972 Clinical Trial.

5

2D versus 3D radiation therapy for prostate carcinoma: a direct comparison of dose volume parameters.

Sale CA, Yeoh EE, Scutter S, Bezak E. Sale CA, et al. Among authors: yeoh ee. Acta Oncol. 2005;44(4):348-54. doi: 10.1080/02841860510029815. Acta Oncol. 2005. PMID: 16120543

6

Assessment of normal tissue complications following prostate cancer irradiation: comparison of radiation treatment modalities using NTCP models.

Takam R, Bezak E, Yeoh EE, Marcu L. Takam R, et al. Among authors: yeoh ee. Med Phys. 2010 Sep;37(9):5126-37. doi: 10.1118/1.3481514. Med Phys. 2010. PMID: 20964232

7

Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.

Takam R, Bezak E, Yeoh EE. Takam R, et al. Among authors: yeoh ee. Phys Med Biol. 2009 Feb 7;54(3):611-25. doi: 10.1088/0031-9155/54/3/009. Epub 2009 Jan 6. Phys Med Biol. 2009. PMID: 19124952

8

Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-kappaB, COX-1, and COX-2.

Yeoh A, Gibson R, Yeoh E, Bowen J, Stringer A, Giam K, Logan R, Keefe D. Yeoh A, et al. Cancer Treat Rev. 2006 Dec;32(8):645-51. doi: 10.1016/j.ctrv.2006.08.005. Cancer Treat Rev. 2006. PMID: 17046165 Review.

9

Matrix metalloproteinase expression is altered in the small and large intestine following fractionated radiation in vivo.

Stansborough RL, Al-Dasooqi N, Bateman EH, Bowen JM, Keefe DMK, Logan RM, Yeoh ASJ, Yeoh EEK, Stringer AM, Gibson RJ. Stansborough RL, et al. Among authors: yeoh eek. Support Care Cancer. 2018 Nov;26(11):3873-3882. doi: 10.1007/s00520-018-4255-5. Epub 2018 May 12. Support Care Cancer. 2018. PMID: 29754212

10

A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2.

Yeoh AS, Gibson RJ, Yeoh EE, Bowen JM, Stringer AM, Giam KA, Keefe DM. Yeoh AS, et al. Among authors: yeoh ee. Mol Cancer Ther. 2007 Aug;6(8):2319-27. doi: 10.1158/1535-7163.MCT-07-0113. Mol Cancer Ther. 2007. PMID: 17699727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters